CBIO - Catalyst Biosciences Inc
Close
0.5113
-0.014 -2.719%
Share volume: 483,723
Last Updated: Mon 30 Oct 2023 09:00:00 PM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$0.53
-0.01
-2.65%
View ratios
Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | |
---|---|---|---|---|---|
Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | |
Report Date | 2022-05-09 | 2022-08-15 | 2022-11-14 | 2023-03-30 | |
Assets | |||||
Total Assets | 40.274 M | 83.373 M | 31.019 M | 28.444 M | |
Current Assets | 36.703 M | 81.308 M | 30.246 M | 28.206 M | |
Inventories | 0.000 | 0.000 | 0.000 | 0.000 | |
Other Current Assets | 1.322 M | 914.000 K | 2.156 M | 1.540 M | |
Short Term Investments | 1.322 M | 914.000 K | 2.156 M | 1.540 M | |
Total Receivables | 564.000 K | 5.000 M | 5.000 M | 5.000 M | |
Current Cash | 34.817 M | 75.394 M | 23.090 M | 21.666 M | |
Total Non-current Assets | 3.571 M | 2.065 M | 773.000 K | 238.000 K | |
Property Plant Equipment | 857.000 K | 164.000 K | 124.000 K | 4.000 K | |
Other Assets | 472.000 K | 168.000 K | 168.000 K | 168.000 K | |
Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | |
Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | |
Liabilities and shareholders’ equity | |||||
Total Liabilities and shareholders’ equity | 40.274 M | 83.373 M | 31.019 M | 28.444 M | |
Total liabilities | 13.190 M | 4.311 M | 1.644 M | 16.824 M | |
Total current liabilities | 13.190 M | 4.311 M | 1.644 M | 16.824 M | |
Accounts Payable | 4.706 M | 1.037 M | 41.000 K | 7.752 M | |
Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | |
Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | |
Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | |
Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | |
Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | |
Total Shareholder equity | 27.084 M | 79.062 M | 29.375 M | 11.620 M | |
Common stock | 31.456 M | 31.477 M | 31.485 M | 31.765 M | |
Retained earnings | -417.230 M | -365.598 M | -370.482 M | -410.936 M |